Issue 1/2011
Content (32 Articles)
The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer
Gary J. R. Cook, Ram Venkitaraman, Aslam S. Sohaib, Valerie J. Lewington, Sue C. Chua, Robert A. Huddart, Christopher C. Parker, David D. Dearnaley, Alan Horwich
18F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging
Michael McCarthy, Teck Siew, Andrew Campbell, Nat Lenzo, Nigel Spry, Justin Vivian, Laurence Morandeau
Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging
Kathy Schilling, Deepa Narayanan, Judith E. Kalinyak, Juliette The, Maria Victoria Velasquez, Simone Kahn, Matthew Saady, Ravinder Mahal, Larraine Chrystal
Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[18F]fluoro-17β-oestradiol PET
Tetsuya Tsujikawa, Yoshio Yoshida, Yasushi Kiyono, Tetsuji Kurokawa, Takashi Kudo, Yasuhisa Fujibayashi, Fumikazu Kotsuji, Hidehiko Okazawa
18F-FDG PET and biomarkers for tumour angiogenesis in early breast cancer
Ashley M. Groves, Manu Shastry, Manuel Rodriguez-Justo, Anmol Malhotra, Raymondo Endozo, Timothy Davidson, Tina Kelleher, Kenneth A. Miles, Peter J. Ell, Mohammed R. Keshtgar
The rising PET: the increasing use of choline PET/CT in prostate cancer
Arturo Chiti, Maria Picchio
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
Paolo Castellucci, Chiara Fuccio, Domenico Rubello, Riccardo Schiavina, Ivan Santi, Cristina Nanni, Vincenzo Allegri, Gian Carlo Montini, Valentina Ambrosini, Stefano Boschi, Giuseppe Martorana, Maria Cristina Marzola, Stefano Fanti
The role of 18F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients’ treatment decision making?
Ahmet Bilici, Bala Basak Oven Ustaalioglu, Mesut Şeker, Umut Kefeli, Nesrin Canpolat, Bulent Tekinsoy, Sule Ozugur, Mahmut Gumus
Post-treatment [18F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma
Hyun Hoon Chung, Jae Weon Kim, Keon Wook Kang, Noh-Hyun Park, Yong-Sang Song, June-Key Chung, Soon-Beom Kang
Early response assessment in prostate carcinoma by 18F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models
Nobuyuki Oyama, Yoko Hasegawa, Yasushi Kiyono, Masato Kobayashi, Yasuhisa Fujibayashi, Datta E. Ponde, Carmen Dence, Michael J. Welch, Osamu Yokoyama
FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position
Irene A. Burger, David A. Scheiner, David W. Crook, Valerie Treyer, Thomas F. Hany, Gustav K. von Schulthess
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Rosalba Mansi, Xuejuan Wang, Flavio Forrer, Beatrice Waser, Renzo Cescato, Keith Graham, Sandra Borkowski, Jean Claude Reubi, Helmut R. Maecke
Development of new folate-based PET radiotracers: preclinical evaluation of 68Ga-DOTA-folate conjugates
Melpomeni Fani, Xuejuan Wang, Guillaume Nicolas, Christelle Medina, Isabelle Raynal, Marc Port, Helmut R. Maecke
In vivo 18F-FDG tumour uptake measurements in small animals using Cerenkov radiation
Federico Boschi, Laura Calderan, Daniela D’Ambrosio, Mario Marengo, Alberto Fenzi, Riccardo Calandrino, Andrea Sbarbati, Antonello E Spinelli
PET imaging of αvβ3 integrin expression in tumours with 68Ga-labelled mono-, di- and tetrameric RGD peptides
Ingrid Dijkgraaf, Cheng-Bin Yim, Gerben M. Franssen, Robert C. Schuit, Gert Luurtsema, Shuang Liu, Wim J. G. Oyen, Otto C. Boerman
Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data
V. Schulz, I. Torres-Espallardo, S. Renisch, Z. Hu, N. Ojha, P. Börnert, M. Perkuhn, T. Niendorf, W. M. Schäfer, H. Brockmann, T. Krohn, A. Buhl, R. W. Günther, F. M. Mottaghy, G. A. Krombach
Improved quantification in multiple-pinhole SPECT by anatomy-based reconstruction using microCT information
Christian Vanhove, Michel Defrise, Axel Bossuyt, Tony Lahoutte
Radionuclide imaging of bone marrow disorders
Ali Agool, Andor W. J. M. Glaudemans, Hendrikus H. Boersma, Rudi A. J. O. Dierckx, Edo Vellenga, Riemer H. J. A. Slart
PET/CT in paediatric oncology: clinical usefulness and dosimetric concerns
Giovanni Lucignani, Diego De Palma
The potential pitfalls of low-activity protocols in PET/CT imaging
Garry McDermott, Gareth Iball, Andrew Scarsbrook
Reply to: The potential pitfalls of low-activity protocols in PET/CT imaging
Iain Murray, Norbert Avril
Erratum to: Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology
Albert Flotats, Ignasi Carrió, Denis Agostini, Dominique Le Guludec, Claudio Marcassa, Michael Schäfers, G. Aernout Somsen, Mustafa Unlu, Hein J. Verberne
Don’t blame the bones!
Imene Zerizer, Jane Cameron, Onn Min Kon, Nikhil A. Kapse, Ranju T. Dhawan
EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting
M. Lassmann, C. Chiesa, G. Flux, M. Bardiès
Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC)
Albert Flotats, Juhani Knuuti, Matthias Gutberlet, Claudio Marcassa, Frank M. Bengel, Philippe A. Kaufmann, Michael R. Rees, Birger Hesse